• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 102208-906
Device Problem Imprecision (1307)
Patient Problem Hypoglycemia (1912)
Event Date 08/10/2023
Event Type  Injury  
Manufacturer Narrative
This report is being submitted retrospectively as part of internal review.The user complained of discrepant measurements between capillary and sensor where the bg was at 48 mg/dl and the sg read 129 mg/dl on (b)(6) 2023, 11:16 pm.A review of the glucose trend data on (b)(6) 2023 confirmed the event described in the complaint, where the sensor recorded a glucose concentration of 129 mg/dl while the user measured a bg of 48 mg/dl at (b)(6) 2023, 11:16 pm.This calibration was marked as a suspicious fingerstick.In associated s4 case #(b)(4), created to document sensor inaccuracies, it was determined that the system observed a temporary period of variability, most likely due to early wear adjustment.It was also observed that some calibrations were entered after gaps in data, and it was recommended that the user may experience less lag by allowing the system to display 1-2 sg readings after a gap before entering a calibration.The overall sensor performance was evaluated after the event, and the sensor is performing with expectations.The user is currently using the system with no further inaccuracy complaints.
 
Event Description
Senseonics was made aware of an incident where the customer had a hypoglycemia event on (b)(6) 2023 at 11:16 pm.The measured blood glucose (bg) value was 48 mg/dl where the sensor glucose (sg) reading was 129 mg/dl.The eversense cgm system did not assert any alerts since the sg value was within normal glucose range.The customer did not require any medical attention and was able to self resolve.No further information was provided by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown 20876-7005
MDR Report Key18117356
MDR Text Key327880220
Report Number3009862700-2023-00292
Device Sequence Number1
Product Code QHJ
UDI-Device Identifier00817491023445
UDI-Public817491023445
Combination Product (y/n)Y
Reporter Country CodeSP
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/12/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date08/31/2023
Device Model Number102208-906
Device Catalogue NumberFG-3500-06-001
Device Lot Number132066
Was Device Available for Evaluation? No
Date Manufacturer Received09/29/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/31/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-